Pepper Bio Partners with Stanford’s Felsher Lab to Identify Therapy Targets for Untreatable, MYC Addicted Lymphatic and Liver Cancers

Leveraging Pepper Bio’s transomics platform, Dean Felsher’s research team will translate academic findings for the development of more efficacious therapies for lymphoma and hepatocellular carcinoma Today, Pepper Bio, the world’s first transomics drug discovery company, announced a collaboration with the Dean Felsher Laboratory at Stanford University. Leveraging Pepper Bio’s unique platform on phosphoproteomics, the two teams aim to identify and validate novel targets for hepatocellular carcinoma and lymphoma within the year. Read on…

Comments Off on Pepper Bio Partners with Stanford’s Felsher Lab to Identify Therapy Targets for Untreatable, MYC Addicted Lymphatic and Liver Cancers

Podcast: De-risking Your Start-Up

Denise Silbe, host of the Harvard Alumni Entrepreneurs podcast, is joined by Jon Hu and Samantha Dale Strasser, PhD, co-founders of Pepper Bio, a Boston-based life sciences start-up expanding the potential for successful drug discovery. By combining their knowledge of industries from venture capital to electrical engineering, Jon and Samantha share lessons that are applicable to almost any start-up. Using transomics technologies, these founders are operating at the cutting edge…

Comments Off on Podcast: De-risking Your Start-Up

Our Bioplatform Approach: A Technical Advantage that Translates into a Business Advantage

By Jon Hu, CEO and Cofounder of Pepper Bio In the last decade, the tech industry has coined the phrase “software is eating the world.” In this decade, it’s going to be biotech that eats the world. Biotechnology, specifically, bioplatforms, are one of the main innovations changing our generation. Exhibit A: Moderna’s mRNA technology platform, which created the COVID-19 vaccine at an unprecedented rate, has changed how we perceive and interact…

Comments Off on Our Bioplatform Approach: A Technical Advantage that Translates into a Business Advantage

A Waze for Drug Discovery? Meet Pepper Bio.

By Jon Hu and Samantha Dale Strasser, PhD When we met over a decade ago as students at Northwestern University, we were struck by our similar experiences of watching our loved ones suffer from untreatable diseases and fighting our own.  Jon recounts, “when I was diagnosed with severe chronic migraines, doctors were able to find a prophylactic treatment regimen so that I could live a normal life. However, when my…

Comments Off on A Waze for Drug Discovery? Meet Pepper Bio.